The Emerging Potential of Diabetes Technology to Improve Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients with Type 1 Diabetes: A Narrative Review
Metabolic dysfunction-associated steatotic liver disease (MASLD) has emerged as an increasingly common comorbidity in individuals with type 1 diabetes (T1D), driven by the rising prevalence of obesity and insulin resistance in this population. Modern diabetes technologies have transformed T1D management and may favorab...